pharma · Hypophosphatasia · Paroxysmal Nocturnal Hemoglobinuria
Alexion Europe SAS
Alexion Europe SAS clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
EU HQ
89 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- EU
- Employees
- 89
- Programs
- 33
- Drugs
- 40
- Patents
- 0
Alexion Europe SAS projects
0 ClinicalTrials.gov programs sponsored by Alexion Europe SAS.
Alexion Europe SAS has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does Alexion Europe SAS have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.